Cryosurgery

Reimbursement Support

Reimbursement Codes and Allowables

Reimbursement Guide

Radical Prostatectomy

Transurethral Resection of the Prostate (TURP)

Watchful Waiting

Benign Prostatic Hyperplasia (BPH)

Prostatitis

Helpful Links

Patient FAQs

Patient Information from Package Insert

Androgen Reduction Graph

Physician Information


	Bayer Global
	Bayer Corporate - USA

	general conditions of use privacy statement imprint © 2007 Bayer HealthCare Pharmaceuticals

Physician Support
Cryosurgery

Viadur is indicated in the palliative treatment of advanced prostate cancer. Bayer is not responsible for, and does not endorse, any of the information found on this page.

Treatment Options


		Chemotherapy
		Cryosurgery
		Hormone therapy
		Radiation therapy
		Radical prostatectomy
		Transurethral resection of the prostate (TURP)
		Watchful waiting

There are many treatments for prostate cancer. The best one for you depends on a number of factors. These include your age, your overall health, and the stage and grade of your cancer.

Be sure to discuss the possible benefits, risks and side effects with each option. The sections here outline some of the general risks and side effects. However, your doctor is the best source of information on your condition. Before you and your doctor select any treatment approach, risks and benefits should be thoroughly discussed.Take the time to research all of your treatment options. Consider getting a second opinion before making a final decision. The most common treatment options for prostate cancer include watchful waiting, radiation, and hormone therapy.

Cryosurgery

Cryosurgery (also called cryotherapy or cryoablation) is used to treat localized prostate cancer by freezing the cells with a metal probe.¹ The tool is placed through an incision between the anus and scrotum and guided into the cancer using transrectal ultrasound.² Rather than removing the prostate (as in conventional surgery) or using radiation therapy with different forms of x-rays, cryotherapy is a method of freezing the prostate and other appropriate nearby tissues to extremely low temperatures.³ This technique is designed to kill all the prostate cancer tissue without having to take the risks involved in carrying out invasive surgery.⁴

What are possible side effects: Frequent urination, burning, blood, pain with urination, penile or scrotal swelling, or impotence.⁵

Who makes a good candidate: Men who already have received radiation treatment, or men who are considering radiation.⁶

Viadur is indicated in the palliative treatment of advanced prostate cancer.

Printer-Friendly Version

References


	Important Safety Considerations Viadur is contraindicated in patients with hypersensitivity to Gn-RH, Gn-RH agonist analogs, or any of the components in Viadur. Viadur is contraindicated in women and pediatric patients and was not studied in women or children. Viadur, like other LH-RH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience a worsening of symptoms or onset of new symptoms including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, and spinal cord compression. The most comment systemic side effects were hot flashes (67.9%), asthenia (7.6%), gynecomastia (6.9%), depression (5.3%), and sweating (5.3%). The most common local side effects were bruising (34.6%) and burning (5.6%).
	Distributed and Marketed by:	Manufactured by:
	Bayer HealthCare Pharmaceuticals 6 West Belt, Wayne, NJ 07470 USA
	© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation. The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.